CASP3 and chronic myelogenous leukemia, BCR-ABL1 positive: The combinational treatment of 17AAG and histone deacetylase inhibitor, suberoylanilide hydroxamic acid, caused mitochondrial damage, activated caspases 3 and 9, and induced apoptosis in CML cells.